Illumisoft Announces Plans with CHAIR for Canadian Hospital Research Program to Evaluate SaniLume
Vancouver, British Columbia--(Newsfile Corp. - October 28, 2026) - Illumisoft Lighting Corp. (TSXV: UVC) (OTCQB: FUVCF) ("Illumisoft" or the "Company") announces that it has collaborated with the Coalition for Community & Healthcare Acquired I
Technologies, Biotechnologies, Soins de santé et hôpitaux, Produits ménagers / de consommation / cosmétiques
2026-10-28 9:12 AM EDT | Illumisoft Lighting Corp.
Envoy Medical Updates Third Quarter 2026 Earnings Call Time to 8:00 A.M. ET on Thursday, November 5th
White Bear Lake, Minnesota--(Newsfile Corp. - October 28, 2026) - Envoy Medical® Inc. (NASDAQ: COCH) ("Envoy Medical" or the "Company"), a hearing health and neuroprosthetics company pioneering fully implanted hearing solutions, today announced that it has updated the time of its conference call to discuss financial results for the third quarter ended September 30, 2026. The conference call will now be held at 8:00 A.M. ET on Thursday, November 5, 2026. The Company will report its
Biotechnologies, Soins de santé et hôpitaux
2026-10-28 8:30 AM EDT | Envoy Medical, Inc.
WELL Health and HEALWELL Announce Competition Bureau Has Concluded Its Merger Review and Issued a No Action Letter
British Columbia and Toronto, Ontario--(Newsfile Corp. - October 28, 2026) - WELL Health Technologies Corp. (TSX: WELL) (OTCQX: WHTCF) (the "Company" or "WELL"), a digital healthcare company focused on positively impacting health outcomes by leveraging technology to empower healthcare practitioners and their patients globally, and HEALWELL AI Inc. (TSX: AIDX) ("HEALWELL"), a healthcare artificial intelligence company focused on preventative care, today announce
Technologies, Logiciels, Soins de santé et hôpitaux, Santé
2026-10-28 6:00 AM EDT | WELL Health Technologies Corp.
HEALWELL and WELL Health Announce Competition Bureau has Concluded Its Merger Review and Issued a No Action Letter
Ontario and Vancouver, British Columbia--(Newsfile Corp. - October 28, 2026) - HEALWELL AI Inc. (TSX: AIDX) (OTCQX: HWAIF) ("HEALWELL" or the "Company"), a healthcare artificial intelligence company focused on preventative care, and WELL Health Technologies Corp. (TSX: WELL) ("WELL"), a digital healthcare company focused on positively impacting health outcomes by leveraging technology to empower healthcare practitioners and their patients globally, toda
Technologies, Soins de santé et hôpitaux
2026-10-28 6:00 AM EDT | HEALWELL AI
medmix Reaches 10 Million Parts Milestone with Sustainable Shadow Printing Technology
Baar, Switzerland--(Newsfile Corp. - October 28, 2026) - medmix has produced 10 million parts using Shadow Printing, now in production at all three Beauty sites in Germany, the USA, and Brazil. The milestone reflects growing demand from cosmetics brands for packaging that combines premium aesthetics with greater sustainability. B
Technologies, Construction / bâtiments, Soins de santé et hôpitaux, Produits ménagers / de consommation / cosmétiques
2026-10-28 4:04 AM EDT | medmix AG
Envoy Medical to Report Third Quarter 2026 Financial Results on Thursday, November 5th
White Bear Lake, Minnesota--(Newsfile Corp. - October 27, 2026) - Envoy Medical® Inc. (NASDAQ: COCH) ("Envoy Medical" or the "Company"), a hearing health and neuroprosthetics company pioneering fully implanted hearing solutions, today announced it will report its financial results for the third quarter ended September 30, 2026, on Thursday, November 5, 2026. Following the release of its financial results, the Company will host a conference call at 4:30 P.M. ET on the same day.
Biotechnologies, Soins de santé et hôpitaux
2026-10-27 8:30 AM EDT | Envoy Medical, Inc.
Adia Med Reports No Serious Adverse Events in First Cohort of Pediatric Autism Study; Enrollment Continues
Winter Park, Florida--(Newsfile Corp. - October 26, 2026) - Adia Med Inc. (OTCQB: ADIA) today reported interim safety observations from the first cohort of its randomized Phase 1/2 investigational study in children with autism spectrum disorder (ASD). Investigators reported no serious adverse events in either study arm and no events requiring reporting to the Institutional Review Board (IRB). Enrollment continues under the protocol's staggered schedule, and first-cohort participants remain in
Soins de santé et hôpitaux, Santé
2026-10-26 8:00 AM EDT | Adia Med Inc.
Theralase Provides Bladder Cancer Clinical Study Update
Toronto, Ontario--(Newsfile Corp. - October 26, 2026) - Theralase® Technologies Inc. (TSXV: TLT) (OTCQB: TLTFF) ("Theralase®" or the "Company"), a clinical-stage pharmaceutical company dedicated to the research and development of energy-activated small molecules for the safe and effective destruction of various cancers, bacteria and viruses, is providing an update on its Phase II Bacillus Calmette-Guérin ("BCG")-Unresponsive Non-Muscle Inva
Technologies, Biotechnologies, Soins de santé et hôpitaux, Pharmaceutique
2026-10-26 7:00 AM EDT | Theralase Technologies Inc.
Global Hemp Group Appoints Mickey Goldstein as Chief Financial Officer, Appoints Davidson & Company as Auditor
Vancouver, British Columbia--(Newsfile Corp. - October 23, 2026) - Global Hemp Group Inc. (CSE: GHG) (FSE: GHG0) (OTC PINK: GBHPF) ("GHG" or the "Company") is pleased to announce the appointment of Mickey Goldstein, CPA, CA, as Chief Financial Officer, effective immediately. Ms. Goldstein succeeds Christopher Cherry. Ms. Goldstein is Director, Accounting Advisory at Crowe MacKay LLP, where she provides strategic financial and advisory services to priv
Biotechnologies, Soins de santé et hôpitaux, Pharmaceutique, Cannabis
2026-10-23 9:59 AM EDT | Global Hemp Group Inc.
Aurora Spine Announces Publication of REFINE Study's 12-Month Results in the International Journal of Spine Surgery
Carlsbad, California--(Newsfile Corp. - October 22, 2026) - Aurora Spine Corporation (TSXV: ASG) (OTCQB: ASAPF) ("Aurora Spine" or the "Company"), a developer and manufacturer of minimally invasive spinal implants and interventional pain management technologies, today announced the publication of the REFINE study's 12-month results in the International Journal of Spine Surgery. Published online on October 9, 2026, the article reports on a prospective, obse
2026-10-22 5:56 PM EDT | Aurora Spine Corporation
Envoy Medical Announces Reverse Stock Split
White Bear Lake, Minnesota--(Newsfile Corp. - October 22, 2026) - Envoy Medical® Inc. (NASDAQ: COCH) ("Envoy Medical" or the "Company"), a hearing health and neuroprosthetics company pioneering fully implanted hearing solutions, today announced that it will implement a 1-for-10 reverse stock split of its outstanding shares of Class A common stock ("Common Stock"), effective at 12:01 a.m. Eastern Time on October 26, 2026 (the
Biotechnologies, Soins de santé et hôpitaux
2026-10-22 8:30 AM EDT | Envoy Medical, Inc.
CareRx Corporation to Host Third Quarter 2026 Financial Results Conference Call on Thursday, November 5, 2026 at 8:30 a.m. ET
Toronto, Ontario--(Newsfile Corp. - October 22, 2026) - CareRx Corporation (TSX: CRRX) ("CareRx" or the "Company") today announced it will host a conference call to discuss its third quarter 2026 financial results on Thursday, November 5, 2026, at 8:30 a.m. Eastern Time (ET). The Company expects to report its third quarter 2026 financial results for the period ended September 30, 2026, after market close on Wednesday, November 4, 2026. Telephone Dia
2026-10-22 7:00 AM EDT | CareRx Corporation
TelyRx to Host Third Quarter 2026 Financial Results Conference Call on Friday, November 6, 2026 at 8:30 am ET
Clearwater, Florida--(Newsfile Corp. - October 22, 2026) - TelyRx Holdings Inc. (TSX: TELY) (OTCQX: TELYF) ("TelyRx" or the "Company"), a vertically integrated, technology-enabled healthcare and pharmacy services company, today announced it will host a conference call and webcast to discuss its third quarter 2026 financial results on Friday, November 6, 2026, at 8:30 a.m. Eastern Time (ET). The Company expects to report its third quarter 2026 financial results for the period end
Soins de santé et hôpitaux, Santé
2026-10-22 7:00 AM EDT | TelyRx
The Untold Story of Rick Hansen's Man In Motion World Tour Comes to the Big Screen Across Canada in November
Richmond, British Columbia--(Newsfile Corp. - October 21, 2026) - Man In Motion: The Rick Hansen Story will be a special event release by Cineplex in selected theatres across Canada on November 1 and 3. Tickets are now on sale. The theatrical release follows the film's world premiere at the Toronto International Film Festival (TIFF), where it received an honourable mention for the Best Canadian Feature Film Award, and its hometown premiere at the Vancouver International Film Festival
Divertissement, Soins de santé et hôpitaux, Services d’édition / d’information, Santé
2026-10-21 10:20 AM EDT | Rick Hansen Foundation
Envoy Medical Hits Six-Month Milestone, Marks Halfway Point in Final Stage of Data Collection, and Highlights Differentiated Device Design
White Bear Lake, Minnesota--(Newsfile Corp. - October 20, 2026) - Envoy Medical® Inc. (NASDAQ: COCH) ("En
Biotechnologies, Soins de santé et hôpitaux
2026-10-20 8:30 AM EDT | Envoy Medical, Inc.
Adia Med Sells 7% Economic Interest in Adia Labs to CEO Larry Powalisz for $350,000 in Cash
Winter Park, Florida--(Newsfile Corp. - October 20, 2026) - Adia Med, Inc. (OTCQB: ADIA) today announced that its Chief Executive Officer, Larry Powalisz, purchased a 7% economic interest in Adia Labs LLC for $350,000 in cash. Under the completed Membership Interest Purchase Agreement, Powalisz purchased seven membership units at $50,000 per unit. The Company has filed a Current Report on Form 8-K relating to the transaction.
Soins de santé et hôpitaux, Santé
2026-10-20 8:00 AM EDT | Adia Med Inc.
FendX Announces Appointment of Daryl Rebeck to Board of Directors
Vancouver, British Columbia--(Newsfile Corp. - October 20, 2026) - FendX Technologies Inc. (CSE: FNDX) (OTCQB: FDXTF) (FSE: E8D0) (the "Company" or "FendX"), a technology company developing surface-protection solutions to reduce the spread of harmful pathogens, is pleased to announce the appointment of Mr. Daryl Rebeck to the board of directors, effective October 19, 2026. Mr. Rebeck's appointment follows the resignation of Mr. Pierre Soulard. Mr. Rebeck is a Cana
Technologies, Soins de santé et hôpitaux, Santé
2026-10-20 7:00 AM EDT | FendX Technologies Inc.
ALZAI Health Corp. Posted for Trading On The OTCQB Venture Market
Toronto, Ontario--(Newsfile Corp. - October 20, 2026) - ALZAI Health Corp. (TSXV: ALZI) (OTCQB: ALZIF) (FSE: H2F) ("ALZAI" or the "Company"), a healthcare technology company developing artificial intelligence-driven disease risk identification solutions, is pleased to announce that its common shares are now quoted for trading on the OTCQB Venture Market ("OTCQB") in the United States under the symbol ALZIF. The OTCQB Venture Market, operated by OTC Markets Group Inc., is a
Technologies, Logiciels, Soins de santé et hôpitaux
2026-10-20 7:00 AM EDT | Alzai Health Corp.
WELL Health Strengthens Privacy and AI Governance Leadership with Appointment of Samara Starkman as Chief Privacy Officer and Vice President, Legal & Regulatory
WELL appoints recognized privacy and healthcare law expert Samara Starkman as Chief Privacy Officer and Vice President, Legal & Regulatory, to lead enterprise privacy, AI governance and healthcare regulatory strategy across the organization. Ms. Starkman previously led the privacy department at Cancer Care Ontario (now part of Ontario Health), co-founded INQ Consulting and was a Partner at INQ Law, advising major Ontario hospitals, pharmaceutica
Technologies, Logiciels, Soins de santé et hôpitaux, Santé
2026-10-20 6:00 AM EDT | WELL Health Technologies Corp.
CardioComm Solutions and CancerCare Manitoba Launch Remote QT/QTc Interval Monitoring Pilot for Breast Cancer Patients
Toronto, Ontario--(Newsfile Corp. - October 19, 2026) - CardioComm Solutions, Inc. (TSXV: EKG) ("CardioComm" or the "Company") announces a collaboration with CancerCare Manitoba ("CCMB") on a pilot study evaluating remote electrocardiogram ("ECG") monitoring for potential QT/QTc interval prolongation after patients begin selected breast cancer drug therapies. During the approximately one-year pilot, patients will use CardioComm's HeartCheck™ CardiBeat handheld ECG monitor f
Technologies, Soins de santé et hôpitaux, Santé
2026-10-19 5:00 PM EDT | CardioComm Solutions, Inc.